Hiroshi Kodaira
- Molecular Biology
- Oncology top 10%
- Biomaterials top 5%
- Pediatrics, Perinatology and Child Health top 5%
- Epidemiology
- Co-authors
- Junko UshikiHiroyuki KusuharaYuichi SugiyamaEiichi FuseS. SpectorTadanori MayumiYasuo TsutsumiHaruhiko Kamada
- Topics
- Cancer therapeutics and mechanisms (7 papers)Nanoparticle-Based Drug Delivery (7 papers)RNA Interference and Gene Delivery (4 papers)
- Cited by
- BiomaterialsOncologyHematology
- Journals
- Proceedings of the National Academy of SciencesNucleic Acids ResearchJournal of Clinical Oncology
- Partner nations
- JapanUnited StatesChina
In The Last Decade
Hiroshi Kodaira
42 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 110
- Molecular Biology 526
- Oncology 440
- Biomaterials 237
- Pediatrics, Perinatology and Child Health 187
- Epidemiology 173
Countries citing papers authored by Hiroshi Kodaira
This map shows the geographic impact of Hiroshi Kodaira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Kodaira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Kodaira more than expected).
Fields of papers citing papers by Hiroshi Kodaira
This network shows the impact of papers produced by Hiroshi Kodaira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Kodaira. The network helps show where Hiroshi Kodaira may publish in the future.
Co-authorship network of co-authors of Hiroshi Kodaira
This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Kodaira. A scholar is included among the top collaborators of Hiroshi Kodaira based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Kodaira. Hiroshi Kodaira is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 40 | |
| 3 | 14 | |
| 4 | 14 | |
| 5 | 38 | |
| 6 | 18 | |
| 7 | 0 | |
| 8 | 36 | |
| 9 | 106 | |
| 10 | 218 | |
| 11 | 3 | |
| 12 | 1 | |
| 13 | 11 | |
| 14 | Innovation and Market Structure | 4 |
| 15 | 57 | |
| 16 | 164 | |
| 17 | 18 | |
| 18 | 31 | |
| 19 | 11 | |
| 20 | 13 |
About Hiroshi Kodaira
Hiroshi Kodaira is a scholar working on Biomaterials, Oncology and Hematology, having authored 45 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (7 papers), Nanoparticle-Based Drug Delivery (7 papers) and RNA Interference and Gene Delivery (4 papers). The work is most often cited by research in Biomaterials (237 citations), Oncology (440 citations) and Hematology (127 citations). Hiroshi Kodaira has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Junko Ushiki, Hiroyuki Kusuhara, Yuichi Sugiyama, Eiichi Fuse, S. Spector, Tadanori Mayumi, Yasuo Tsutsumi, Haruhiko Kamada, Shin‐ichi Tsunoda and Shinsaku Nakagawa. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.